CEO of Raygent Associates
Contributor's Links: Raygent

Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a ... more

ALL CONTRIBUTIONS

Biotech Stocks Are Lagging, Position Your Portfolio For A Q4 Rally With The XBI
Technology stocks dominate gains over six weeks and lead YTD; cloud software, semiconductors and FAANG.
Read
Tough Time To Trade Biotech Stocks, Is The Momentum Market Easing?
Until a new stimulus package emerges and coronavirus transmissions get under control stocks will remain volatile despite raging bullish sentiment.
Read
Speculative Rally In Biotech Today, Is The Correction Over Already?
The economy and the market wants solutions to the pandemic and biotech seems to have breaking news on therapies and vaccines for traders daily.
Read
Biotech Traders Will Face Strong Headwinds
A good day for the market and Biotech IBB up 2.67%, Semis Very Hot SMH up 4.03%.
Read
Biotech Portfolio Review: What To Do Next?
Your biotech portfolio is probably up at least 10% YTD because the IBB is up ~17% and the XBI up 18.35%. Do you raise cash or go more defensive with the life science positions you own?
Read
Coronavirus Stocks: Take A Breather - The Easy Trades Have Been Done
The coronavirus trade is not over because COVID Cases are spiking and the scientific news buffets stocks every day. The gains since mid-March are huge so that adding to existing positions in your portfolio will become more difficult.
Read

Comments

Latest Comments
Regulatory News For Rare Disease Products - Hot Stocks: BLUE, ICPT, SRPT
5 years ago

Getting trial information and following them is the hard part as it takes too much time. Just sett up the stocks in a Yahoo portfolio and track daily. The WEB site of the Company usually lets you know if trial results are coming in and when.

In this article: BLUE, ICPT, SRPT
Biotech Buzz Is Broken
5 years ago

Here is the YTD for KITE down 4.7%:

www.google.com/finance

In this article: JUNO, KITE, GILD, REGN
2015 Biotech Stock Preview: Rhythms Of The “PermaBull”
5 years ago

prefer a fund like FBIOX but XBI will work when the market heats up

In this article: XLV, FBT, FBIOX, GILD
1 to 3 of 3 comments

STOCKS I FOLLOW

ABAX ABAXIS Inc.
ALXN Alexion Pharmaceuticals, Inc.
AMRI Albany Molecular Research, Inc.
CBST Cubist Pharmaceuticals Inc.
GPRO GoPro, Inc.
QDEL Quidel Corporation

TWEETS

PERSONAL BLOG

Latest Posts
Biotech Investing Strategy For 2020: Part I… Update-1 Jan 24
We remain on hold for taking on new positions. Biotech and healthcare stocks have made nice gains so let’s get through the earnings cycle.
Asco Rally Fizzles: The Nascent Rally In Biotech Stocks Fades
ASCO Rally Fizzles Two Weeks ahead of May 31-June 4 Meeting: XBI down 0.9% to $83.

Work Experience

CEO
Raygent Associates
January 1990 - Present (31 years 2 months)
Biotechnology Intelligence www.raygent.com

Education

Penn State University
BS
Biochemistry
Rutgers University
MBA
Business

Publications